Boonlorm Wankarn, Nisityotakul Panat
Department of Radiology, Vachira Phuket Hospital, Phuket, Thailand.
Front Radiol. 2025 Jul 18;5:1613940. doi: 10.3389/fradi.2025.1613940. eCollection 2025.
Transarterial microembolization (TAME) has gained recognition as a minimally invasive treatment for chronic musculoskeletal pain, demonstrating significant efficacy with a favorable safety profile ( 1, 2). However, complications remain underreported. This case report describes the first documented severe adverse event in a patient with a chronic venous ulcer undergoing TAME for a micro arteriovenous fistula (AVF). The patient developed significant complications, including extensive leg swelling, skin changes, and cellulitis requiring prolonged inpatient care. These findings highlight the importance of patient selection and embolic agent considerations to mitigate potential risks associated with TAME.
经动脉微栓塞术(TAME)已被公认为是一种治疗慢性肌肉骨骼疼痛的微创方法,显示出显著疗效且安全性良好(1,2)。然而,并发症的报告仍然不足。本病例报告描述了首例有记录的严重不良事件,该事件发生在一名患有慢性静脉溃疡的患者身上,其因微动静脉瘘(AVF)接受TAME治疗。该患者出现了严重并发症,包括腿部广泛肿胀、皮肤改变以及需要长期住院治疗的蜂窝织炎。这些发现凸显了患者选择和栓塞剂考量对于减轻与TAME相关潜在风险的重要性。